Marie Stenmark‐Askmalm

1.9k total citations
13 papers, 260 citations indexed

About

Marie Stenmark‐Askmalm is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Marie Stenmark‐Askmalm has authored 13 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Marie Stenmark‐Askmalm's work include BRCA gene mutations in cancer (5 papers), Cancer-related Molecular Pathways (4 papers) and Genetic factors in colorectal cancer (4 papers). Marie Stenmark‐Askmalm is often cited by papers focused on BRCA gene mutations in cancer (5 papers), Cancer-related Molecular Pathways (4 papers) and Genetic factors in colorectal cancer (4 papers). Marie Stenmark‐Askmalm collaborates with scholars based in Sweden, Denmark and Netherlands. Marie Stenmark‐Askmalm's co-authors include Peter Söderkvist, M Łysiak, Martin Hallbeck, Charlotte Bratthäll, Anna‐Lotta Hallbeck, Annika Malmström, Peter Milos, Olle Stål, Mohamed Ali Mosrati and Annika Lindblom and has published in prestigious journals such as Cancer, Scientific Reports and PLoS Genetics.

In The Last Decade

Marie Stenmark‐Askmalm

13 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie Stenmark‐Askmalm Sweden 8 121 101 78 64 56 13 260
Man Chun John United States 10 103 0.9× 146 1.4× 26 0.3× 58 0.9× 116 2.1× 19 285
Erin D. Lucas Australia 8 163 1.3× 125 1.2× 73 0.9× 14 0.2× 14 0.3× 9 372
Pawel Grabowski Sweden 8 125 1.0× 34 0.3× 21 0.3× 109 1.7× 77 1.4× 8 332
Maithili P. Dalvi United States 5 177 1.5× 77 0.8× 60 0.8× 35 0.5× 6 0.1× 7 296
Seog Young Kim South Korea 7 129 1.1× 203 2.0× 77 1.0× 26 0.4× 19 0.3× 9 327
Göknur Giner Australia 5 170 1.4× 183 1.8× 95 1.2× 15 0.2× 23 0.4× 12 318
Mark Vitucci United States 9 157 1.3× 58 0.6× 78 1.0× 136 2.1× 11 0.2× 9 355
Regina Lichti Binz United States 10 193 1.6× 66 0.7× 29 0.4× 27 0.4× 24 0.4× 21 310
Sebastien M. Joruiz United States 6 200 1.7× 197 2.0× 57 0.7× 13 0.2× 15 0.3× 12 296
Trinidad Caldés Spain 4 118 1.0× 164 1.6× 107 1.4× 16 0.3× 37 0.7× 4 269

Countries citing papers authored by Marie Stenmark‐Askmalm

Since Specialization
Citations

This map shows the geographic impact of Marie Stenmark‐Askmalm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Stenmark‐Askmalm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Stenmark‐Askmalm more than expected).

Fields of papers citing papers by Marie Stenmark‐Askmalm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Stenmark‐Askmalm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Stenmark‐Askmalm. The network helps show where Marie Stenmark‐Askmalm may publish in the future.

Co-authorship network of co-authors of Marie Stenmark‐Askmalm

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Stenmark‐Askmalm. A scholar is included among the top collaborators of Marie Stenmark‐Askmalm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Stenmark‐Askmalm. Marie Stenmark‐Askmalm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Stenmark‐Askmalm, Marie, Fredrik Persson, Anna‐Lotta Hallbeck, et al.. (2025). Characterisation of heritable TP53-related cancer syndrome in Sweden—a nationwide study of genotype-phenotype correlations in 90 families. European Journal of Human Genetics. 33(4). 513–522. 1 indexed citations
2.
Johansson, Hemming, Gustav Silander, Marie Stenmark‐Askmalm, et al.. (2023). Whole‐body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study. Cancer. 129(6). 946–955. 1 indexed citations
3.
Öfverholm, Anna, Therese Törngren, Anna Rosén, et al.. (2023). Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer. BMC Cancer. 23(1). 738–738. 5 indexed citations
4.
Tham, Emma, Yvonne Brandberg, Håkan Åhlström, et al.. (2022). Whole-Body MRI Surveillance—Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53). Cancers. 14(2). 380–380. 7 indexed citations
5.
Stedingk, Kristoffer von, Anders Kvist, Ulf Kristoffersson, et al.. (2021). Prevalence of germline pathogenic variants in 22 cancer susceptibility genes in Swedish pediatric cancer patients. Scientific Reports. 11(1). 5307–5307. 15 indexed citations
6.
Stedingk, Kristoffer von, Thomas Wiebe, Lars Hjorth, et al.. (2020). Increased Cancer Risk in Families with Pediatric Cancer Is Associated with Gender, Age, Diagnosis, and Degree of Relation to the Child. Cancer Epidemiology Biomarkers & Prevention. 29(11). 2171–2179. 2 indexed citations
7.
Malmström, Annika, M Łysiak, Ingrid Jakobsen Falk, et al.. (2019). ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide. The Pharmacogenomics Journal. 20(2). 213–219. 11 indexed citations
8.
Salomé, Jenny von, Philip S. Boonstra, Masoud Karimi, et al.. (2017). Genetic anticipation in Swedish Lynch syndrome families. PLoS Genetics. 13(10). e1007012–e1007012. 9 indexed citations
9.
Lagerstedt‐Robinson, Kristina, Anna Rohlin, Beatrice Melin, et al.. (2016). Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. Oncology Reports. 36(5). 2823–2835. 42 indexed citations
10.
Mosrati, Mohamed Ali, Annika Malmström, M Łysiak, et al.. (2015). TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma. Oncotarget. 6(18). 16663–16673. 103 indexed citations
11.
Malmström, Annika, Martin Hallbeck, Peter Milos, et al.. (2015). MTR-09ABCB1 AS PREDICTIVE MARKER FOR POOR SURVIVAL IN PATIENTS WITH GLIOBLASTOMA TREATED WITH RADIOTHERAPY AND CONCOMITANT AND ADJUVANT TEMOZOLOMIDE. Neuro-Oncology. 17(suppl 5). v126.1–v126. 1 indexed citations
12.
Jansson, Agneta, Jonas Carlsson, Petter Storm, et al.. (2007). A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer. Breast Cancer Research and Treatment. 106(1). 57–64. 11 indexed citations
13.
Stenmark‐Askmalm, Marie, et al.. (1994). Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer. European Journal of Cancer. 30(2). 175–180. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026